SAHPRA
sahpra.org.za
Imported from official source
Regulator in South Africa; safety publications from its own official source.
- Type
- Regulator
- Scope
- ZA · national
- Website
- sahpra.org.za
- Feed
- Atom
Publications 9
-
Important Notice on Cybersecurity Threats
02 October 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to alert all stakeholders to phishing emails currently circulating with the subject lines “Urgent” and “Foll...
Announcement -
SAHPRA Reinforces Its Commitment to Radiation Safety at IAEA General Conference
18 September 2026 – The South African Health Products Regulatory Authority (SAHPRA) is participating in the 70th International Atomic Energy Agency (IAEA) General Conference in Vienna, underscoring...
Announcement -
SAHPRA and Lesotho strengthen regional collaboration for regulatory excellence
14 September 2026 – The South African Health Products Regulatory Authority (SAHPRA) hosted a three-day bilateral engagement with Lesotho’s Radiation Protection Agency (RPA) at its Pretoria head off...
Announcement -
South Africa Maintains WHO Maturity Level 3 (ML3) for Vaccine Regulation
26 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) is pleased to share that the World Health Organization (WHO) has confirmed that South Africa has achieved and mainta...
Announcement -
SAHPRA Reaffirms the Safety of Routine Childhood Vaccination
20 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to reaffirm the public that routine childhood vaccines used in South Africa remain safe based on ongoing evid...
Announcement -
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal Outcomes
20 August 2026 The South African Health Products Regulatory Authority (SAHPRA) wishes to remind healthcare professionals of the risk of angioedema during treatment with angiotensin-converting enzym...
Announcement -
SAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressure
Pretoria, 16 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) has initiated the recall of four batches of Enalapril 10mg Arya, a medicine commonly used to treat high bl...
Announcement -
SAHPRA Inspires Rhodes Science Students to Shape the Future of Health Regulation
Pretoria, 20 July 2026 – Approximately 200 pharmacy and science students at Rhodes University gathered at the University’s Makhanda campus, formerly Grahamstown, on 9 July to explore careers in hea...
Announcement -
Health regulators warn against the use or dispensing of recalled Semaglutide and Tirzepatide
Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby war...
Announcement